UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 17, 2018
Accession Number:
0001193125-18-107549
Submission Type:
POS AM
CIK:
0001042418
Company Name:
HedgePath Pharmaceuticals, Inc.
File Number:
333-212092